BGI Genomics Co Ltd (300676):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BGI Genomics Co Ltd (300676) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7921
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BGI Genomics Co Ltd (BGI) is a provider of sequencing services. The company offerings include DNA, RNA, non-invasive prenatal testing, newborn genetic screening, reproductive health screening, customized sequencing services and clinical exome sequencing services. It also offers clinical and research solutions for translational oncology and immunology. BGI offers its services in various research areas, such as agriculture and food science; cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. It offers its services to various medical institutions, research institutions and other public partners. The company operates through its subsidiaries across Europe, the Americas, China, Japan and Asia. BGI is headquartered in Yantian, Shenzhen, China.

BGI Genomics Co Ltd (300676) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BGI Genomics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BGI Genomics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BGI Genomics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BGI Genomics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BGI Genomics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BGI Genomics Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Kangmei Pharma to Form Joint Venture with BGI Genomics 10
BGI Genomics Partners with Sanguine BioSciences 11
BGI Genomics and Hummingbird Diagnostics to Enter into Partnership 12
Equity Offering 13
BGI Genomics Raises USD80 Million in IPO 13
Complete Genomics Spin-Off Genos Research 14
Acquisition 15
BGI Genomics May Sell Stake in Its Equipment Unit for up to USD1 Billion 15
BGI Genomics Co Ltd – Key Competitors 16
BGI Genomics Co Ltd – Key Employees 17
BGI Genomics Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
May 04, 2018: BGI Announces New Partnerships and 8th Anniversary Milestone in US 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
BGI Genomics Co Ltd, Medical Equipment, Key Facts, 2017 2
BGI Genomics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BGI Genomics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BGI Genomics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BGI Genomics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BGI Genomics Co Ltd, Deals By Market, 2012 to YTD 2018 8
BGI Genomics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kangmei Pharma to Form Joint Venture with BGI Genomics 10
BGI Genomics Partners with Sanguine BioSciences 11
BGI Genomics and Hummingbird Diagnostics to Enter into Partnership 12
BGI Genomics Raises USD80 Million in IPO 13
Complete Genomics Spin-Off Genos Research 14
BGI Genomics May Sell Stake in Its Equipment Unit for up to USD1 Billion 15
BGI Genomics Co Ltd, Key Competitors 16
BGI Genomics Co Ltd, Key Employees 17
BGI Genomics Co Ltd, Other Locations 18
BGI Genomics Co Ltd, Subsidiaries 18

List of Figures
BGI Genomics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BGI Genomics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BGI Genomics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BGI Genomics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BGI Genomics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BGI Genomics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BGI Genomics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BGI Genomics Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BGI Genomics Co Ltd (300676):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ferrovial, S.A.:企業の戦略・SWOT・財務情報
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tgb Banquets And Hotels:企業の戦略・SWOT・財務分析
    Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report Summary Tgb Banquets And Hotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Theravasc Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theravasc Inc (Theravasc) is a pharmaceutical company that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product includes TV1001SR, a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases a …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Hermes International SA:企業の戦略・SWOT・財務情報
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tanabe Research Laboratories USA Inc (Tanabe Research Laboratories USA), a subsidiary of Mitsubishi Tanabe Pharma Corp is a healthcare research center that discovers and develops biological drugs. The laboratory conducts research on metabolics, immunology and inflammation. Its products are u …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • InVivo Therapeutics Corp:企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • Sembcorp Industries Ltd:企業の戦略・SWOT・財務情報
    Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Sembcorp Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CSC Steel Holdings Berhad:企業の戦略・SWOT・財務情報
    CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Taishin International Bank Co Ltd:企業の戦略・SWOT・財務分析
    Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Koninklijke Philips N.V. (PHIA)-エネルギー分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Tong Ren Tang Technologies Co Ltd (1666):企業の財務・戦略的SWOT分析
    Summary Tong Ren Tang Technologies Co Ltd (TRTT), a subsidiary of Beijing Tong Ren Tang Co Ltd is a pharmaceutical company that manufactures and supplies Chinese medicines. The company’s products comprise Chinese medicine, healthy food and maier hai cosmetics. It offers products in the forms of pill …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析
    Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆